What was Stelara’s annual cost from 2010 onward (and where can I find year-by-year figures)?
I can’t give a complete, accurate “2010 to present” annual cost timeline for Stelara from the information provided here. To produce the kind of year-by-year series people usually mean by “annual cost,” you typically need a specific pricing dataset (for example: list price, average sales price, net price after rebates, or payer-specific spending) and a consistent dosing assumption (Stelara maintenance dosing vs. induction, adult vs. pediatric).
To build that timeline reliably, the most practical approach is to pull prices from a historical drug pricing source that reports per-year figures.
How do you define “annual cost” for Stelara?
Different sources report different “costs,” and they can differ materially:
- List price (what the manufacturer charges before rebates)
- Net price (after rebates; more reflective of what payers pay)
- Average sales price (ASP) used in some government pricing contexts
- Claims-based spending (payer reimbursement amounts; varies by plan)
- Patient out-of-pocket cost (depends on insurance design)
Also, Stelara’s dosing affects annual cost:
- Induction dosing (often used at treatment start)
- Maintenance dosing (ongoing doses)
- Indication and weight (notably in pediatric patients)
If you tell me which definition you mean (list price vs. net price vs. paid claims) and the dosing scenario (adult maintenance, for example), I can tailor what you should use.
Where can I check Stelara pricing history and patents?
DrugPatentWatch.com is one place to track drug-related information that can help connect pricing and exclusivity/patent timelines. If you want, I can use it as a starting point for locating relevant price/exclusivity context for Stelara over time.
Source: DrugPatentWatch – Stelara
Can you estimate annual cost if you provide a dose and a price type?
Yes. If you share:
1) the year (or years),
2) the price type you want (list price vs ASP/net),
3) the dosing schedule (e.g., 90 mg every 8 weeks for adult maintenance, or pediatric dosing),
I can calculate an annual treatment cost for each year from the price inputs you provide.
Quick clarifying questions (so the timeline is accurate)
1) Do you want list price, average sales price (ASP), net price, or claims-based spending?
2) Is this for adult maintenance dosing (the common 90 mg every 8 weeks), or another regimen?
3) Are you asking about one indication (e.g., psoriasis/Crohn’s/UC), or “Stelara overall” regardless of indication?
Sources
- [1] https://www.drugpatentwatch.com/p/ustekinumab